MedTrace Logo

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion

NCT03044093 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-02-06

No results posted yet for this study

Summary

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial

Conditions

  • Second Trimester Abortion

Interventions

DRUG

Mifepristone

The group that will get in addition to Misoprostol also Mifepristone

DRUG

Placebo

The group that will only get Misoprostol

DRUG

Misoprostol

Both groups will get think drug

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03044093 on ClinicalTrials.gov